GE HealthCare Technologies Inc. (GEHC) — Capital Reinvestment Ratio

Latest as of March 2026: 0.61x

GE HealthCare Technologies Inc. (GEHC) has a Capital Reinvestment Ratio of 0.61x as of March 2026, meaning it reinvests 1% of its operating cash flow ($290.00 Million) in capital expenditures ($178.00 Million). See GE HealthCare Technologies Inc. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.61x
Capex / Operating Cash Flow

Operating Cash Flow

$290.00 Million
USD

Capital Expenditures

$178.00 Million
USD

Data as of

Mar 2026
Most recent filing

GE HealthCare Technologies Inc. Capital Reinvestment Ratio (2019–2025)

This chart tracks GE HealthCare Technologies Inc.'s Capital Reinvestment Ratio across 7 annual periods.

Annual Capital Reinvestment Ratio for GE HealthCare Technologies Inc. (2019–2025)

Year-by-year Capital Reinvestment Ratio for GE HealthCare Technologies Inc. from 2019 to 2025. For live market cap and broader valuation context, see market value of GE HealthCare Technologies Inc..

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.24x $1.99 Billion $482.00 Million ▲ +18.0%
2024 0.21x $1.95 Billion $401.00 Million ▲ +11.6%
2023 0.18x $2.10 Billion $387.00 Million ▲ +25.6%
2022 0.15x $2.11 Billion $310.00 Million ▼ -4.9%
2021 0.15x $1.61 Billion $248.00 Million ▲ +0.5%
2020 0.15x $1.69 Billion $259.00 Million ▼ -7.7%
2019 0.17x $1.99 Billion $331.00 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow